Ra Medical Systems, Inc. (RMED) Q4 2019 Earnings Conference Call March 10, 2020 4:30 PM ET Company Participants Jody Cain – LHA Investor Relations Andrew Jackson – Interim Chief Executive Officer and Chief Financial Officer Conference Call Participants Anthony Vendetti – Maxim Group Drew Hoey – Piper Sandler Craig Bijou – Cantor Fitzgerald Operator Ladies and gentlemen, thank you for standing by. Welcome to the Ra Medical Systems Fourth Quarter 2019 Conference Call. At this time, all participants are in a l ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission file number: 001-38677 Ra Medical Systems, Inc. (Exact name of Registrant as specified in its charter) (State or other jurisdiction of incorporation or ...

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2019 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission file number: 001-38677 Ra Medical Systems, Inc. (Exact name of Registrant as specified in its charter) Delaware 38-3661826 N/A (State or other jurisdiction ...

Ra Medical Systems, Inc. (RMED) Q1 2019 Earnings Conference Call May 13, 2019 4:30 PM ET Company Participants Kevin McCabe – LHA Investor Relations Dean Irwin – Chief Executive Officer Tom Fogarty – Chief Commercial Officer Andrew Jackson – Chief Financial Officer Conference Call Participants Matthew O’Brien – Piper Jaffray Bruce Nudell – SunTrust Craig Bijou – Cantor Fitzgerald Anthony Vendetti – Maxim Group Operator Ladies and gentlemen, thank you for standing by. Welcome to the Ra Medical Systems First Q ...

For the Transition Period From to Commission file number: 001-38677 Ra Medical Systems, Inc. (Exact name of Registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (State or other jurisdiction of incorporation or org ...

Ra Medical Systems, Inc. (RMED) Q4 2018 Earnings Conference Call March 14, 2019 4:30 PM ET Company Participants Kevin McCabe - LHA Investor Relations Dean Irwin - Chief Executive Officer, Chief Technology Officer and Chairman of the Board of Directors Thomas Fogarty - Chief Commercial Officer Andrew Jackson - Chief Financial Officer Conference Call Participants Andrew Stafford - Piper Jaffray Bruce Nudell - SunTrust Robinson Humphrey, Inc. Anthony Vendetti - Maxim Group, LLC Operator Ladies and gentlemen, t ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission file number: 001-38677 Ra Medical Systems, Inc. (Exact name of Registrant as specified in its charter) (State or other jurisdiction of incorporation or organiza ...

Ra Medical Systems, Inc. NYSE: RMED Corporate Presentation January 2019 Disclaimer 2 Certain statements in this presentation and the accompanying oral commentary are forward-looking statements. These statements relate to future events or the future financial performance of Ra Medical Systems, Inc. (the "Company") and involve known and unknown risks, uncertainties and other factors that may cause the actual results, levels of activity, performance or achievements of the Company or its industry to be material ...